
Article 1 
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 28 March 2018.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

((1)) in the sixth column, expiration of approval, of row 73, Thiram, the date is replaced by ‘30 April 2019’;
((2)) in the sixth column, expiration of approval, of row 74, Ziram, the date is replaced by ‘30 April 2019’;
((3)) in the sixth column, expiration of approval, of row 82, Quinoxyfen, the date is replaced by ‘30 April 2019’;
((4)) in the sixth column, expiration of approval, of row 89, Pseudomonas chlororaphis Strain: MA 342, the date is replaced by ‘30 April 2019’;
((5)) in the sixth column, expiration of approval, of row 90, Mepanipyrim, the date is replaced by ‘30 April 2019’;
((6)) in the sixth column, expiration of approval, of row 92, Thiacloprid, the date is replaced by ‘30 April 2019’;
((7)) in the sixth column, expiration of approval, of row 123, Clodinafop, the date is replaced by ‘30 April 2019’;
((8)) in the sixth column, expiration of approval, of row 124, Pirimicarb, the date is replaced by ‘30 April 2019’;
((9)) in the sixth column, expiration of approval, of row 125, Rimsulfuron, the date is replaced by ‘30 April 2019’;
((10)) in the sixth column, expiration of approval, of row 126, Tolclofos-methyl, the date is replaced by ‘30 April 2019’;
((11)) in the sixth column, expiration of approval, of row 127, Triticonazole, the date is replaced by ‘30 April 2019’;
((12)) in the sixth column, expiration of approval, of row 129, Clopyralid, the date is replaced by ‘30 April 2019’;
((13)) in the sixth column, expiration of approval, of row 130, Cyprodinil, the date is replaced by ‘30 April 2019’;
((14)) in the sixth column, expiration of approval, of row 131, Fosetyl, the date is replaced by ‘30 April 2019’;
((15)) in the sixth column, expiration of approval, of row 132, Trinexapac, the date is replaced by ‘30 April 2019’;
((16)) in the sixth column, expiration of approval, of row 133, Dichlorprop-P, the date is replaced by ‘30 April 2019’;
((17)) in the sixth column, expiration of approval, of row 134, Metconazole, the date is replaced by ‘30 April 2019’;
((18)) in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by ‘30 April 2019’;
((19)) in the sixth column, expiration of approval, of row 136, Triclopyr, the date is replaced by ‘30 April 2019’;
((20)) in the sixth column, expiration of approval, of row 137, Metrafenone, the date is replaced by ‘30 April 2019’;
((21)) in the sixth column, expiration of approval, of row 138, Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713, the date is replaced by ‘30 April 2019’;
((22)) in the sixth column, expiration of approval, of row 139, Spinosad, the date is replaced by ‘30 April 2019’;
((23)) in the sixth column, expiration of approval, of row 140, Thiamethoxam, the date is replaced by ‘30 April 2019’.
